MCAS symptoms are multi-system and episodic: flushing, hives, itching, abdominal pain and diarrhea, a racing heart, lightheadedness, wheezing, headaches, and brain fog that flare and settle. Mast cell activation syndrome affects many organs at once, which is exactly why its symptoms overlap so closely with long COVID, ME/CFS, and dysautonomia, and why so many people are dismissed before anyone connects the pattern.
Key takeaways
- Mast cell activation syndrome symptoms hit multiple systems at once: skin, gut, heart rate and blood pressure, airways, and cognition.
- The same clusters, fatigue, brain fog, palpitations, and gut trouble, appear in long COVID and ME/CFS, so the conditions are easy to confuse and often coexist.
- MCAS is diagnosed clinically. There is no single validated diagnostic blood biomarker for it, which is part of why patients feel unseen.
- Research links post-viral illness to altered immune signaling, including cytokines and chemokines that a broad panel can measure as context.
- Measuring that signaling does not diagnose MCAS. It gives objective, trackable data to bring to your own doctor.
What are the main MCAS symptoms?
The defining feature of MCAS is that symptoms are episodic and cross more than one body system at the same time. When mast cells release their mediators inappropriately, the effects show up wherever those cells sit, which is nearly everywhere. Common features include:
- Skin: flushing, hives, itching, swelling, and dermographism (skin that welts when scratched).
- Gut: cramping, nausea, diarrhea, reflux, and food or chemical sensitivities that seem to come and go.
- Cardiovascular: a pounding or racing heart, lightheadedness, and blood pressure swings, often on standing.
- Airway: nasal congestion, throat tightness, and wheezing.
- Neurologic: headaches, brain fog, poor concentration, and fatigue.
Triggers are individual and frustrating to pin down: heat, exercise, stress, alcohol, certain foods, or nothing obvious at all. The flare-and-settle rhythm is a big reason symptoms get waved away between episodes.
Why do MCAS symptoms overlap with long COVID and ME/CFS?
Read the MCAS symptom list next to a long COVID or ME/CFS description and the overlap is hard to miss. Deep fatigue, post-exertional worsening, brain fog, palpitations, dizziness on standing, and gut disturbance appear across all of them. The CDC overview of long-term effects after COVID-19 and the CDC ME/CFS overview both describe multi-system, fluctuating illness that reads much like a mast cell picture.
Part of the reason is shared biology. All of these conditions involve the immune and autonomic nervous systems, and mast cells sit at the crossroads of both. An infection can prime immune signaling that does not fully switch off, and mast cells are highly responsive to that ongoing signal. This is why some people carry more than one of these labels at the same time. It also means "which condition is it" is often the wrong question; the honest answer is that they share mechanisms and frequently travel together. Our companion piece on post-viral fatigue symptoms maps the fatigue side of that overlap.
Is there a blood test that confirms MCAS symptoms?
Not a definitive one. MCAS is diagnosed clinically, from the pattern of multi-system symptoms, objective mediator evidence when it can be captured, and response to mediator-targeting treatment. There is no single validated diagnostic blood biomarker for MCAS, the same honest limitation that applies to ME/CFS and fibromyalgia. The classic mediator tests, a serum tryptase and 24-hour urinary mediators, are timing-sensitive and often normal between flares. For a full walk-through of what those tests do and do not cover, see what the standard MCAS workup covers and misses.
Because these conditions overlap, an objective read on the wider inflammatory state can be useful context. Research using deep immune profiling has reported that specific patterns of circulating immune proteins can distinguish people with long COVID from those who recovered, which single routine labs do not. A study in Nature (Klein et al., 2023) is one example of that kind of multi-marker signaling work. This is a research and monitoring lens on inflammation, not a diagnosis of MCAS.
How does inflammation profiling fit when your symptoms are dismissed?
The hardest part of overlapping, invisible symptoms is being believed. When routine labs come back normal, many people are told they are fine, which is not the same as being well. A broad inflammation profile answers a narrower question with objective numbers: what is your inflammatory-signaling picture right now, and how does it change over time. It measures cytokines and chemokines such as IL-6, TNF, and CXCL10 (IP-10), benchmarks each against a healthy reference range, and can be repeated to track shifts. It does not measure tryptase or histamine, so it is context around the mast cell mediators rather than a mediator test, and it is not a diagnosis. If you want to see the specific markers, you can see what Muno Mirror measures and review the results with your own doctor, who remains the person to confirm any diagnosis and guide care.
Frequently asked questions
Can you have MCAS and long COVID at the same time?
Yes. These conditions share immune and autonomic mechanisms and frequently coexist. Many people meet criteria for more than one, and an infection can be a common trigger. Because the symptom clusters overlap heavily, careful clinical evaluation is needed to sort out what is contributing to what.
What symptoms distinguish MCAS from ME/CFS?
MCAS tends to feature allergic-type and episodic signs such as flushing, hives, itching, and clear reactions to triggers like heat, food, or alcohol, alongside the shared fatigue and brain fog. ME/CFS is defined by post-exertional malaise, unrefreshing sleep, and cognitive or orthostatic problems. The overlap is large, and a clinician is best placed to distinguish them.
Is there a definitive blood test for MCAS symptoms?
No. There is no single validated diagnostic blood biomarker for MCAS. Diagnosis is clinical and uses mediator tests such as tryptase and urinary metabolites as support, though these are often normal between flares. Broad inflammation profiling is informational context, not a diagnostic test.
Does measuring inflammation tell me if I have MCAS?
No. A cytokine and chemokine panel measures the broader inflammatory-signaling context, not the mast cell mediators, and it cannot confirm or rule out MCAS. It gives objective, trackable data for research and informational use. Any diagnosis should come from your own doctor.